Don't forget that the NIH is absolutely at odds with the FDAs position on EPA and CVE risk reduction - almost all of the non-Japanese/JELIS research papers are published and/or funded by the NIH. That said, why are they repeating REDUCE-IT in such a tiny population of 40?